0001104659-24-060000.txt : 20240510
0001104659-24-060000.hdr.sgml : 20240510
20240510172214
ACCESSION NUMBER: 0001104659-24-060000
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240508
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sherman Darren
CENTRAL INDEX KEY: 0001723524
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39421
FILM NUMBER: 24936086
MAIL ADDRESS:
STREET 1: C/O MOTUS GI HOLDINGS, INC.
STREET 2: 1301 EAST BROWARD BLVD, 3RD FLOOR
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc.
CENTRAL INDEX KEY: 0001814114
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
BUSINESS PHONE: 646-343-9298
MAIL ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2
DATE OF NAME CHANGE: 20200603
4
1
tm2414108-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-08
0
0001814114
Orchestra BioMed Holdings, Inc.
OBIO
0001723524
Sherman Darren
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE
NEW HOPE
PA
18938
1
1
0
0
See Remarks
0
Common Stock, par value $0.0001 per share ("Common Stock")
2024-05-08
4
A
0
176667
0
A
800112
D
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 26,500 RSUs will vest on May 25, 2025, and (ii) the remaining 150,167 RSUs will vest in equal installments on August 25, 2025, November 25, 2025, December 22, 2025, May 25, 2026, August 25, 2026, December 22, 2026, March 25, 2027, May 25, 2027, August 25, 2027, November 25, 2027, March 25, 2028 and May 25, 2028, subject to the Reporting Person's continuous service through such dates.
President and Chief Operating Officer
/s/ Matthew R. Schob, Attorney-in-Fact
2024-05-10